Fundz

Vivosense Announces Closing Of $25M Series A Financing

PRIVATEMar 30, 2022

Amount Raised

$25 Million

Round Type

Series A

Newport BeachBiotechnologyHealthcareHealth Care

Description

VivoSense, Inc., (“VivoSense”) an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data, today announced the close of a $25 Million Series A financing round. The financing will accelerate the development of novel digital biomarkers and improve digital clinical outcome assessments (COAs). VivoSense will also use this financing to expand and refine its informatics platform for data analysis from wearable and connected technologies to deliver validated digital COAs for life science research.

Quick answer

VivoSense, Inc. raised $25 Million in a Series A round, dated March 30, 2022. VivoSense, Inc. is based in Newport Beach, California, United States.

How much did VivoSense, Inc. raise?
VivoSense, Inc. raised $25 Million in a Series A round on March 30, 2022.
What does VivoSense, Inc. do?
VivoSense, Inc., is an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data.
Where is VivoSense, Inc. based and how big is it?
VivoSense, Inc. is based in Newport Beach, California, United States.
Who are the decision-makers at VivoSense, Inc?
Fundz holds 1 contact at VivoSense, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as VivoSense, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Tempest Therapeutics raised $15M on May 11, 2022.
  • Nuo Therapeutics raised $3.5M on May 6, 2022.
  • Treace raised $150M (Debt Financing) on May 2, 2022.
  • Zetagen Therapeutics raised $9.6M on April 29, 2022.
  • CytoDyn raised $1.9M (Seed) on April 22, 2022.
  • Optimize Systems raised $2M (Seed) on April 19, 2022.

Who to call at VivoSense, Inc., and when

A new round usually means VivoSense, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VivoSense, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VivoSense, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VivoSense, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VivoSense, Inc.

Location

27 DORIAN

Newport Beach, California, United States

About

VivoSense, Inc., is an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data. We are focused on healthcare research & delivery, clinical trials and patient wellness. VivoSense’s hypothesis-driven framework provides analytical and clinical validation leading to FDA approval. The proprietary VivoSense® software enables the creation and validation of novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials. For more information visit www.vivosense.com. We are on Twitter. Follow us @vivosense.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VivoSense, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsDudley T., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for VivoSense, Inc.'s next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

VivoSense, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.